Compound ID | 88
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Broad spectrum activity |
| Description: | A cephalosporin |
| Institute where first reported: | Cubist Pharmaceuticals (Merck), USA |
| Year first mentioned: | 2013 |
| Development status: | Experimental |